We take a look at Oxford’s biotech and life sciences hub to discover what makes this historical city a hotspot for scientific innovation.
U.S. pharmaceutical giant Gilead Sciences has announced plans to acquire Oxford University biotech spinout company MiroBio in an all-cash deal worth $405 million. MiroBio is a clinical-stage company ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results